Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma

被引:19
作者
Hara, T
Noma, T
Yamashiro, Y
Naito, K
Nakazawa, A
机构
[1] Yamaguchi Univ, Sch Med, Dept Urol, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi 7558505, Japan
来源
UROLOGICAL RESEARCH | 2001年 / 29卷 / 01期
关键词
clinical parameter; posttranscriptional regulation; renal cell carcinomas; telomerase; telomeric repeat amplification protocol; telomerase reverse transcriptase;
D O I
10.1007/s002400000156
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To investigate the relationship between the telomerase activity levels and clinicopathological features of tumors, we quantified the telomerase activities of 23 renal cell carcinomas (RCCs) and four non-cancerous tissues, using a modified telomeric repeat amplification protocol assay, and assessed the hTERT mRNA levels of these samples by reverse transcription-polymerase chain reaction analysis. Elevated levels of telomerase activity had correlation with tumor stages as well as the degree of nuclear grades. Our findings suggested that telomerase activity is a useful indicator for tumor aggressiveness in RCCs. However, hTERT mRNA levels in RCCs had no correlation with nuclear grades and tumor stages. The telomerase activities and the hTERT mRNA levels in cancer cells were not always in parallel. These results suggested that telomerase activity is regulated in a posttranscriptional manner as well as a post-translational manner in tumor cells.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 28 条
[1]   Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice [J].
Artandi, SE ;
Chang, S ;
Lee, SL ;
Alson, S ;
Gottlieb, GJ ;
Chin, L ;
DePinho, RA .
NATURE, 2000, 406 (6796) :641-645
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase [J].
Counter, CM ;
Meyerson, M ;
Eaton, EN ;
Ellisen, LW ;
Caddle, SD ;
Haber, DA ;
Weinberg, RA .
ONCOGENE, 1998, 16 (09) :1217-1222
[4]   THE RNA COMPONENT OF HUMAN TELOMERASE [J].
FENG, JL ;
FUNK, WD ;
WANG, SS ;
WEINRICH, SL ;
AVILION, AA ;
CHIU, CP ;
ADAMS, RR ;
CHANG, E ;
ALLSOPP, RC ;
YU, JH ;
LE, SY ;
WEST, MD ;
HARLEY, CB ;
ANDREWS, WH ;
GREIDER, CW ;
VILLEPONTEAU, B .
SCIENCE, 1995, 269 (5228) :1236-1241
[5]  
Kanaya T, 1998, INT J CANCER, V78, P539, DOI 10.1002/(SICI)1097-0215(19981123)78:5<539::AID-IJC2>3.0.CO
[6]  
2-I
[7]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[8]   Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) [J].
Kim, NW ;
Wu, F .
NUCLEIC ACIDS RESEARCH, 1997, 25 (13) :2595-2597
[9]   Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma [J].
Kinoshita, H ;
Ogawa, O ;
Mitsumori, K ;
Kakehi, Y ;
Terachi, T ;
Yoshida, O .
JOURNAL OF UROLOGY, 1998, 159 (01) :245-251
[10]   Telomerase is controlled by protein kinase Cα in human breast cancer cells [J].
Li, H ;
Zhao, LL ;
Yang, ZY ;
Funder, JW ;
Liu, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) :33436-33442